Joël Guigay

基本信息

Career Trajectory

Bio

L'activité du Professeur Guigay a été récompensée par de nombreuses distinctions officielles : Chevalier de la Légion d'honneur (2004), Chevalier de l'Ordre National du Mérite (2000), Médaillé de bronze au titre des travaux scientifiques et techniques (1999), Prix de la Société Française de Médecine des Armées (1989) et Médaillé de la Défense Nationale "agrafe Service de Santé" échelon bronze (1988).

Research Interests

Papers共 375 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Cetuximab every 2 weeks versus standard weekly dosing administration schedule

Carsten Bokemeyer,Fortunato Ciardiello,Olivier Dubreuil,Joel Guigay,Stefan Kasper,Per Pfeiffer,Carmine Pinto,Kensei Yamaguchi,Takayuki Yoshino,Christoph Zielinski,Regina Esser,Josep Tabernero

FUTURE ONCOLOGY（2024）

Cited0Views0WOSBibtex

Cetuximab Every 2 Weeks Versus Standard Weekly Dosing Administration Schedule

Carsten Bokemeyer,Fortunato Ciardiello,Olivier Dubreuil,Joel Guigay,Stefan Kasper,Per Pfeiffer,Carmine Pinto,Kensei Yamaguchi,Takayuki Yoshino,Christoph Zielinski,Regina Esser,Josep Tabernero

Future Oncologyno. 7 (2024): 393-407

Cited0Views0Bibtex

854MO Avelumab-cetuximab-radiotherapy (RT) Versus Standards of Care in Patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN): Final Analysis of Randomized Phase III GORTEC 2017-01 REACH Trial

Y. Tao,A. Auperin, X. Sun,X. Liem,C. Sire,L. Martin,Y. Pointreau,C. Borel,M-C. Kaminsky-Forrett,J. Miroir,F. Rolland,A. Coutte,F. Clatot, L. Sinigaglia,J. Thariat,C. Even,E.B. Saada,J. Guigay, J. Bourhis

Annals of Oncology（2024）

Cited0Views0Bibtex

Tumor Kinetics Modeling Outperforms Best Overall Response for Prediction of Survival in Head and Neck Squamous Cell Carcinoma

Kevin Atsou,Anne Aupérin,J. Guigay,Sébastien Salas,Sébastien Benzekry

openalex（2024）

Cited0Views0Bibtex

Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma

Kevin Atsou,Anne Auperin,Joel Guigay,Sebastien Salas,Sebastien Benzekry

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY（2024）

Cited0Views0WOSBibtex

Cetuximab Versus Methotrexate in First-Line Treatment of Older, Frail Patients with Inoperable Recurrent or Metastatic Head and Neck Cancer (ELAN UNFIT): a Randomised, Open-Label, Phase 3 Trial

LANCET HEALTHY LONGEVITYno. 3 (2024): e182-e193

Cited2Views0WOSBibtex

938P Nivolumab (nivo) in Recurrent And/or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M SCCHN): Real-World Effectiveness, Quality of Life (qol) of Patients and Their Caregivers in France (pronihn Study)

C. Le Tourneau,C. Even,S. Salas,Y. Pointreau,P. Ceruse,E. Babin,J. Fayette,V. Rondeau,V. Grumberg,F-E. Cotte, A. Govart,K. Baumstarck,J. Guigay

Annals of Oncology (2023): S590-S590

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 375 篇Author StatisticsCo-AuthorSimilar Experts